Milestone Pharmaceuticals, Inc. (MIST)
1.04
-0.02
(-1.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Milestone Pharmaceuticals Price to Book Value : 7.107 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 7.107 |
| August 21, 2026 | 7.210 |
| August 20, 2026 | 7.039 |
| August 19, 2026 | 7.381 |
| August 18, 2026 | 7.312 |
| August 17, 2026 | 7.517 |
| August 14, 2026 | 7.517 |
| August 13, 2026 | 7.312 |
| August 12, 2026 | 7.688 |
| August 11, 2026 | 8.679 |
| August 10, 2026 | 8.611 |
| August 07, 2026 | 8.337 |
| August 06, 2026 | 8.064 |
| August 05, 2026 | 7.825 |
| August 04, 2026 | 7.996 |
| August 03, 2026 | 7.654 |
| July 31, 2026 | 7.586 |
| July 30, 2026 | 7.859 |
| July 29, 2026 | 7.107 |
| July 28, 2026 | 7.312 |
| July 27, 2026 | 7.722 |
| July 24, 2026 | 7.927 |
| July 23, 2026 | 8.201 |
| July 22, 2026 | 8.132 |
| July 21, 2026 | 8.406 |
| Date | Value |
|---|---|
| July 20, 2026 | 8.064 |
| July 17, 2026 | 8.098 |
| July 16, 2026 | 8.474 |
| July 15, 2026 | 8.679 |
| July 14, 2026 | 8.884 |
| July 13, 2026 | 8.747 |
| July 10, 2026 | 8.747 |
| July 09, 2026 | 8.952 |
| July 08, 2026 | 8.337 |
| July 07, 2026 | 8.816 |
| July 06, 2026 | 9.021 |
| July 02, 2026 | 9.021 |
| July 01, 2026 | 9.021 |
| June 30, 2026 | 9.157 |
| June 29, 2026 | 4.346 |
| June 26, 2026 | 4.052 |
| June 25, 2026 | 4.085 |
| June 24, 2026 | 4.150 |
| June 23, 2026 | 4.248 |
| June 22, 2026 | 4.281 |
| June 18, 2026 | 4.248 |
| June 17, 2026 | 4.281 |
| June 16, 2026 | 4.215 |
| June 15, 2026 | 4.281 |
| June 12, 2026 | 4.150 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 0.6877 |
| NervGen Pharma Corp. | 17.48 |
| Clearmind Medicine, Inc. | 0.149 |
| Lexaria Bioscience Corp. | 3.676 |
| Target Group, Inc. (Canada) | -- |
Price to Book Value Related Metrics
| PS Ratio | 52.34 |
| Price | 1.04 |
| Earnings Yield | -66.71% |
| Market Cap | 129.48M |